Aurobindo's product is already filed with the Drugs Controller General of India (DCGI) and is expected to be approved soon
Jeet will be a trusted partner in cardiovascular care
Lupin actively contributes to alleviating the burden of COPD for patients across the nation
CrisprBits has developed a platform to build rapid, precise, and affordable POC tests for a wide range of disease and health conditions
Collaboration combines clinical research expertise with artificial intelligence capabilities to help drug developers better understand the probability of clinical success for their assets
CiplaMed 2.0 leverages advanced analytics and automation
Combination creates an integrated provider of drug development and regulatory consulting services serving a complementary client base
The survey findings for Delhi-NCR revealed that speech sound disorders exhibit higher prevalence rates in the 6-12 years age group
Exor’s investment in Philips will not result in any share dilution and has been carried out by way of on-market share purchases
Newcastle University’s Dr Srikanth Ramaswamy has been announced as one of six new Fellows selected for the 2023 Lister prize
Subscribe To Our Newsletter & Stay Updated
